Development of a thermal cross-linking heparinization method and its application to small caliber vascular prostheses

ASAIO Journal

Volumn 42, Issue 5, 1996, Pages

  Iwai, Yoshihiro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CROSSLINKING; GRAFTS; LIVING SYSTEMS STUDIES; MEDICAL PROBLEMS; MICROSCOPIC EXAMINATION; POLYTETRAFLUOROETHYLENES;

ANTITHROMBOGENICITY; CAROTID ARTERIES; DOGS; FIBROBLASTS; HEPARINIZATION;

BLOOD VESSEL PROSTHESES;

HEPARIN; POLITEF;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PROSTHESIS; CELL INFILTRATION; CONCENTRATION RESPONSE; CROSS LINKING; HEAT TOLERANCE; HEPARINIZATION; NONHUMAN; PROSTHESIS MATERIAL; SURGICAL APPROACH; TREATMENT OUTCOME;

EID: 0030250910     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199609000-00076     Document Type: Article

References (17)

1. Wildevuur Ch R H, van der Lei B, Schakenraad JM: Basic aspect of the regeneration of small-calibre neoarteries in biodegradable vascular grafts in rats. Biomaterials 8: 418-422, 1987.
2. Gott VL, Whiffen JD, Datton RC: Heparin bonding on colloidal graphite surfaces. Science 142: 1297, 1963.
3. Tanzawa H, Mori Y, Harumiya N, et al: Preparation and evaluation of a new antithrombogenic heparinized hydrophilic polymer for use in cardiovascular system. Trans ASAIO 19: 1884, 1973.
4. Mori Y, Nagaoka S, Masubuti Y, et al: The effect of released heparin from the heparinized hydrophilic polymer (HRSD) on the process of thrombus formation. Trans ASAIO 24: 736, 1978.
5. Kim SW, Ebert CD, Lin JY, McRen JC: Nonthronbogenic polymers: pharmaceutical approaches. ASAIO J 6: 76, 1983.
6. Larm O, Larsson R, Olsson P: A new nonthronbogenic surface prepared by selective covalent binding via a modified reducing terminal residue. Biomater Med Dev Artif Organs 11: 161, 1983.
7. Raghunath K, Biswas G, Panduranga Rao K, Joseph KT, Chvapil M: Some characteristics of collagen-heparin complex. J Biomed Mater Res 17: 613-621, 1983.
8. Noishiki Y, Miyata T: A simple method to heparinize biological materials. J Biomed Mater Res 20: 337-346, 1986.
9. Mohamad F, Olsen DB: Reduced platelet adhesion and activation of coagulation factors on polyurethane treated with albumin-IgG complex. 32nd Annual Meeting ASAIO, Anaheim, May 1986.
10. Jacob H, Okano T, Lin J, Kim SW: PgE1-heparin in conjugate releasing polymer. 12th Annual Meeting of the Society for Biomaterials, Minneapolis, May 1986.
11. Iida K, Kaneko N, Shimomura Y: A new method for heparinization. Jpn J Artif Organs 20: 488-492, 1991.
12. Ma XH, Yasuharu Noishiki, Marat D, et al: Thermal crosslinking for biological degradable materials. 42nd Annual Conference of ASAIO, Washington DC, May 1996.
13. Ma XH, Yasuharu N, Marat D, et al: Application of a colorimetric method to determine heparin content in insoluble collagenous materials. 42nd Annual Conference of ASAIO, Washington DC, May 1996.
14. DelVecchio PJ, Biziou R, Holleran LA, Judge TK, Pinto GL: Inhibition of human scleral fibroblast proliferation with heparin. Ophthalmol Vis Sci 29: 1272, 1988.
15. Wright TC Jr, Johnstone TV, Castellot JJ, Karnovsky MJ: Inhibition cervical epithelial cell growth by heparin and its reversal by EGF. J Cell Physiol 125: 499, 1985.
16. Rifkin DB, Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109: 1-6, 1989.
17. Folkman J, Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.